Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin.

Trial Profile

Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Mar 2017

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Acronyms INTERCEPTOR
  • Most Recent Events

    • 27 Feb 2017 Planned number of patients changed from 278 to 282.
    • 27 Feb 2017 Planned End Date changed from 1 May 2021 to 1 Dec 2021.
    • 27 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Feb 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top